AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceHealth CareGeographicals
Hyperlipidemia, Familial CombinedHyperlipidemiasHypertensionHypertension, PulmonaryTriglyceridesHypolipidemic AgentsLipidsCholesterolBlood PressureIntervention StudiesHypertension, RenalRisk FactorsHypertension, PortalAntihypertensive AgentsCholesterol, LDLHypertriglyceridemiaHypertension, RenovascularTreatment OutcomeHypercholesterolemiaObesityLipoproteinsHyperlipoproteinemia Type IVApolipoproteins ECholesterol, HDLLipid MetabolismHypertension, MalignantApolipoproteins BTime FactorsApolipoproteins CApolipoprotein E2Diabetes MellitusApolipoprotein C-IIIFollow-Up StudiesArteriosclerosisFenofibrateCardiovascular DiseasesLipoprotein LipaseAnticholesteremic AgentsLipoproteins, VLDLXanthomatosisHydroxymethylglutaryl-CoA Reductase InhibitorsPrevalenceDisease Models, AnimalLiverBody WeightDiabetes Mellitus, Type 2Prospective StudiesDietary FatsAtherosclerosisBlood GlucoseLipoproteins, LDLRetrospective StudiesApolipoproteinsCholesterol, VLDLGynostemmaAge FactorsHyperlipoproteinemia Type IIHypertension, Pregnancy-InducedReceptors, LDLDyslipidemiasRisk AssessmentUnited StatesInsulin ResistanceDietMice, Inbred C57BLKidneyCross-Sectional StudiesHeptanoic AcidsHyperlipoproteinemia Type IIIHealth PromotionPoloxamerSex FactorsDiabetes ComplicationsCohort StudiesBody Mass IndexDiet, AtherogenicRats, Sprague-DawleyInsulinOcular HypertensionApolipoprotein A-IPulmonary ArteryCholesterol, DietaryLogistic ModelsQuestionnairesCoronary DiseaseRegression AnalysisPostprandial PeriodFatty LiverRandomized Controlled Trials as TopicChronic DiseasePyrrolesSimvastatinMice, KnockoutComorbiditySeverity of Illness IndexLife StyleBezafibratePatient ComplianceStrokePilot Projects